ASHP Joins the National Infusion Collaborative to Advance Safety and Stewardship of Intravenous Medication Use

Published: April 15, 2024

Today, ASHP is pleased to announce it has joined the National Infusion Collaborative™ (NIC) as it brings together pharmacy and safety leaders across the country to advance patient safety and the stewardship of intravenous medication use.

Formed in partnership with Bainbridge Health and Purdue University’s Regenstrief Center for Healthcare Engineering in 2022, the NIC’s mission is to create an academic, research-driven forum for medication safety leaders to share best practices, learn from a nationwide network of professionals, and promote a zero-harm environment for patients receiving intravenous medications.

As a member organization of the NIC, ASHP will collaborate with Bainbridge Health, Purdue University’s Regenstrief Center for Healthcare Engineering, and other member organizations on research, best practice sharing, and innovative approaches to improve infusion safety practices.

Members of the collaborative include inpatient pharmacy, quality, and safety leaders focused on infusion pump data analytics and safety practices.

The NIC is free to join and is expected to surpass more than 500 hospital members in 2024. ASHP, Bainbridge Health, and Purdue encourage anyone involved with the oversight of infusion pumps, including patient safety organizations and infusion pump manufacturers, to participate.

To join the NIC and learn more, visit the NIC’s website.

Posted April 15, 2024

Advance Your Professional Development

View Other Products

Free Board Exam Prep Resources

The Review & Recertification Reward Program (RRRP) includes free access to exam preparation material + enrollment in a recertification plan billed monthly ($10) during your initial recertification cycle. For ASHP members only.

Learn More
Review & Recertification Reward Program (RRRP)

New Edition Available to Order

AHFS Drug Information® 2024 contains the most dependable drug information available—all in one place. It is the most comprehensive evidence-based source of drug information complete with therapeutic guidelines and off-label uses.

Order Today
AHFS 2024 Drug Information